PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34238748-7	2021	Compared with those in DPN model group, the rats with swertiamarin treatment showed improved hyperalgesia (P < 0.001), decreased expressions of TNF-alpha (P=0.03) and IL-6 (P=0.002), increased expressions of TGF-beta (P=0.04), and decreased expressions of NOXS (P < 0.001), ROS (P < 0.001) and NLRP3 (P=0.002).	swertiamarin	54-66	interleukin 6	Rattus norvegicus	167-171